halothane has been researched along with Bronchopulmonary Dysplasia in 1 studies
Bronchopulmonary Dysplasia: A chronic lung disease developed after OXYGEN INHALATION THERAPY or mechanical ventilation (VENTILATION, MECHANICAL) usually occurring in certain premature infants (INFANT, PREMATURE) or newborn infants with respiratory distress syndrome (RESPIRATORY DISTRESS SYNDROME, NEWBORN). Histologically, it is characterized by the unusual abnormalities of the bronchioles, such as METAPLASIA, decrease in alveolar number, and formation of CYSTS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferrari, LR | 1 |
| Goudsouzian, NG | 1 |
1 trial available for halothane and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
The use of the laryngeal mask airway in children with bronchopulmonary dysplasia.
Topics: Anesthesia Recovery Period; Anesthesia, Inhalation; Blood Pressure; Bronchopulmonary Dysplasia; Carb | 1995 |